We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's What Key Metrics Tell Us About CME (CME) Q2 Earnings
Read MoreHide Full Article
CME Group (CME - Free Report) reported $1.69 billion in revenue for the quarter ended June 2025, representing a year-over-year increase of 10.4%. EPS of $2.96 for the same period compares to $2.56 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $1.68 billion, representing a surprise of +0.51%. The company delivered an EPS surprise of +1.72%, with the consensus EPS estimate being $2.91.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how CME performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Average daily volume (including NYMEX and COMEX): 30.22 million versus the five-analyst average estimate of 29.97 million.
Average rate per contract - Interest rates (including NYMEX and COMEX): $0.48 versus the five-analyst average estimate of $0.48.
Average rate per contract - Equity indexes (including NYMEX and COMEX): $0.64 versus $0.64 estimated by five analysts on average.
Average rate per contract - Foreign exchange (including NYMEX and COMEX): $0.77 compared to the $0.76 average estimate based on five analysts.
Average rate per contract - Energy (including NYMEX and COMEX): $1.14 versus $1.22 estimated by five analysts on average.
Average rate per contract - Agricultural commodities (including NYMEX and COMEX): $1.44 versus $1.40 estimated by five analysts on average.
Average daily volume - Metals (including NYMEX and COMEX): 943 thousand compared to the 935.91 thousand average estimate based on five analysts.
Average rate per contract (including NYMEX and COMEX): $0.69 compared to the $0.70 average estimate based on five analysts.
Average daily volume - Interest rates (including NYMEX and COMEX): 15.47 million compared to the 15.33 million average estimate based on five analysts.
Revenues- Other: $105.9 million compared to the $106 million average estimate based on seven analysts. The reported number represents a change of -1.6% year over year.
Revenues- Market data and information services: $198.1 million versus $195.23 million estimated by seven analysts on average. Compared to the year-ago quarter, this number represents a +13.2% change.
Revenues- Clearing and transaction fees: $1.39 billion versus the seven-analyst average estimate of $1.38 billion. The reported number represents a year-over-year change of +11.1%.
Shares of CME have returned +1.2% over the past month versus the Zacks S&P 500 composite's +5.9% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Here's What Key Metrics Tell Us About CME (CME) Q2 Earnings
CME Group (CME - Free Report) reported $1.69 billion in revenue for the quarter ended June 2025, representing a year-over-year increase of 10.4%. EPS of $2.96 for the same period compares to $2.56 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $1.68 billion, representing a surprise of +0.51%. The company delivered an EPS surprise of +1.72%, with the consensus EPS estimate being $2.91.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how CME performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:View all Key Company Metrics for CME here>>>
Shares of CME have returned +1.2% over the past month versus the Zacks S&P 500 composite's +5.9% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.